BTBD7 inhibitors belong to a specialized class of chemical compounds designed to target and modulate the activity of BTBD7, also known as BTB/POZ domain-containing protein 7. BTBD7 is a protein that contains a BTB/POZ domain, a conserved protein-protein interaction module often involved in forming multiprotein complexes. While the precise functions of BTBD7 are still being elucidated, it has been implicated in various cellular processes, including transcriptional regulation, protein degradation, and potentially cell cycle control. Inhibitors of BTBD7 are developed to interact with this specific protein, potentially influencing its interactions with binding partners, cellular localization, or its roles in cellular processes where BTBD7 is involved.
Structurally, BTBD7 inhibitors are meticulously designed to engage specific regions or binding sites on the BTBD7 protein. This interaction may disrupt the normal functioning of BTBD7, potentially affecting its ability to mediate protein-protein interactions or other molecular functions. The mechanisms by which BTBD7 inhibitors exert their effects can vary, but their primary objective is to serve as valuable tools for researchers studying the roles of BTBD7 in various cellular contexts. Investigating the biochemical and functional aspects of BTBD7 and its modulation by inhibitors can contribute to a deeper understanding of transcriptional regulation, protein-protein interactions, cell cycle control, and the broader field of molecular and cellular biology. Ultimately, this research can offer insights into the intricate molecular mechanisms that govern fundamental cellular functions and their regulation by BTBD7.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a broad-spectrum kinase inhibitor which might impact multiple pathways including those that potentially regulate BTBD7 or similar proteins. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An inhibitor of histone deacetylase, Trichostatin A can influence gene expression and might affect proteins related to BTBD7. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound inhibits DNA methyltransferase and might affect the expression of genes related to BTBD7. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 is a cysteine protease inhibitor. Depending on the functional context, it could influence BTBD7 or its related proteins. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $47.00 $143.00 $680.00 | 16 | |
As an FGFR1 inhibitor, PD173074 might indirectly influence BTBD7 through the FGF signaling pathway. | ||||||
IWP-2 | 686770-61-6 | sc-252928 sc-252928A | 5 mg 25 mg | $96.00 $292.00 | 27 | |
IWP-2 inhibits Wnt processing and secretion, potentially influencing pathways related to BTBD7. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $40.00 $120.00 $480.00 $2141.00 | 47 | |
DAPT is a γ-secretase inhibitor and can affect Notch signaling, which might be related to BTBD7 functionality. | ||||||
LY2090314 | 603288-22-8 | sc-507359 | 5 mg | $175.00 | ||
This compound inhibits GSK-3, potentially affecting Wnt/β-catenin signaling which could be related to BTBD7 functions. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 affects bromodomains leading to modulation of gene expression. It might influence BTBD7 or similar proteins. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
MLN4924 inhibits NEDD8-activating enzyme, affecting protein degradation and might have an impact on BTBD7-related pathways. | ||||||